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administration and long-term renal function.
Methods

Study Subjects
From November 2007 to January 2008, 36 consecutive patients with suspected coronary artery disease who were scheduled for a coronary angiography and who were ≥20 years old with stable sCr levels of <2 mg/dl were eligible for the study. Exclusion criteria were: pregnancy, acute myocardial infarction, multiple myeloma, pulmonary edema, history of allergy to contrast media, recent exposure to contrast media within 2 days of study entry, administration of dopamine, mannitol, diuretics, fenoldopam, or N-acetylcysteine during the intended time of the study, and current treatment with peritoneal dialysis or hemodialysis. Our Institutional Ethics Review Board approved this study, and informed consent was obtained from all patients.
Study Protocol sCr was measured at 12-24 h before the procedure and at 24 h and 1 year after coronary angiography. The estimated glomerular filtration rate (eGFR) was calculated using the level-modified Modification of Diet in Renal Disease equation, modified for the Japanese, where eGFR = 0.741 × 175 × age in years -0.203 × sCr -1.154 and for female sex adjustment, eGFR female = eGFR × 0.742. 13 Urinary F2-isoprostane, a marker Figure 1 . Correlations between volume of contrast medium and changes in (A) serum creatinine (sCr), (B) estimated glomerular filtration rate (eGFR) and (C) urinary F2-isoprostane at 24 h after coronary angiography. Values are expressed as n (%) or mean ± SD. sCr, serum creatinine; eGFR, estimated glomerular filtration rate; ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.
Prediction of Chronic Renal Insufficiency
of oxidative stress, 14 and urinary N-acetyl-β-D-glucosaminidase (NAG) was measured at 12-24 h before and at 24 h after coronary angiography and was normalized to urinary creatinine levels. Urinary F2-isoprostane was extracted and quantitated using an enzyme-linked immunosorbent assay to determine levels of 15-isoprostane F2t (MED.DIA s.r.l., Italy), following the manufacturer's instructions.
A coronary angiography was performed according to standard clinical practice. Iomeprol, a nonionic low-osmolality radiographic contrast agent (Iomeron 350, Eisai Co, Ltd, Tokyo, Japan), was used in all patients for coronary angiography. Infusion of lactated Ringer's solution (1.0-1.5 ml · kg -1 · h -1 ) was initiated 6-8 h before the angiographic procedure and was continued until 12 h after the procedure. 
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Hypertension was defined as a systolic blood pressure (BP) of ≥140 mmHg, a diastolic BP of ≥90 mmHg, or by previous history. Diabetes mellitus was defined as a fasting plasma glucose concentration of ≥126 mg/dl, a casual concentration of ≥200 mg/dl, or a history of previous treatment. Dyslipidemia was defined as a serum total cholesterol concentration of ≥220 mg/dl, serum high-density lipoproteincholesterol concentration of ≤40 mg/dl, serum triglyceride concentration of ≥150 mg/dl, serum low-density lipoproteincholesterol of ≥140 mg/dl, or previous treatment.
Statistical Analysis
Continuous variables are expressed as mean ± standard deviation. Categorical variables are expressed as percentages. Change in eGFR at 1 year after angiography was entered in turn as the continuous dependent variable into a stepwise linear regression model with age (years), male gender, contrast medium (ml/kg BW ), hypertension, diabetes, ACE-I/ARB, diuretics, change in F2-isoprostane at 24 h after angiography (%), change in NAG at 24 h after angiography (%) and change in eGFR at 24 h after angiography (%) as covariates. Each significant predictor that was identified by this analysis was subsequently tested in a multivariable linear correlation. Statistical significance was considered at a level of P<0.05. All analyses were performed using SPSS 14.0 software for Windows (SPSS, Inc, Chicago, IL, USA).
Results
Baseline characteristics of the patients are listed in Table 1 .
Figures 1A, 1B shows the significant relationship between the volume of contrast medium and the changes in sCr and eGFR from baseline to 24 h after coronary angiography (r=0.502; P=0.003, r=-0.432; P=0.012, respectively). We also found a significant relationship between the increase in urinary F2-isoprostane from baseline to 24 h after angiography and the volume of contrast medium (r=0.450; P=0.006, Figure 1C) .
The changes in sCr, eGFR and urinary F2-isoprostane are shown in Table 2 . Both sCr and eGFR improved slightly from baseline at 24 h and worsened slightly at 1 year; the increase in sCr and decrease in eGFR were observed in 52% of patients at 1 year, although there is no significance compared to the baseline values. The change in urinary F2-isoprostane from baseline was also not significant.
The change in sCr and eGFR at 1 year after angiography correlated with the changes in sCr and eGFR at 24 h after angiography (r=0.696; P<0.001, r=0.729; P<0.001, respectively; Figures 2A, 2B) . We also found a significant correlation between the increase in urinary F2-isoprostane at 24 h and the change in sCr and eGFR at 1 year (r=0.541; P=0.004, r=-0.439; P=0.022, respectively; Figures 2C,2D) .
Hypertension and diabetes are major risk factors for worsening renal function. At 1 year after angiography, the ambulatory BP levels and glycated hemoglobin levels did not significantly change compared with baseline (systolic BP, 125.0±17.2 vs. 122.5±12.6 mmHg, P=0.737; diastolic BP, 72.8±12.1 vs. 75.9±12.5 mmHg, P=0.338; glycated hemoglobin, 5.93±0.68 vs. 5.97±0.89%, P=0.796).
Univariate and multivariate linear regression models of increase in eGFR at 1 year after coronary angiography are shown in Table 3 . In univariate analysis, the use of diuretics, the change in eGFR at 24 h after angiography, and the change in F2-isoprostane at 24 h after angiography correlated with the change in eGFR at 1 year after angiography. In multivariate analysis, the increase in eGFR at 1 year after coronary angiography correlated with the change in F2-isoprostane at 24 h after angiography as well as the change in eGFR at 24 h after angiography.
Discussion
The present study is the first to identify a robust relationship between acute oxidative stress and kidney injury triggered by contrast medium administration and long-term renal prognosis.
Creatinine concentration has generally been reported to return to baseline value by 7-10 days after contrast administration. 15 CIN accounts for 12% of the acute kidney injury cases that occur in hospitals, and approximately 30% of patients develop renal dysfunction or chronic renal failure. 16 An animal model using old spontaneously hypertensive male rats showed that high osmolar contrast media could enhance the progression of glomerulosclerosis and renal failure. 17 However, the long-term renal prognosis of patients after exposure to contrast media has not been reported well. In the Change in NAG at 24 h after angiography (%) 0.192 0.337
Other abbreviations see in Table 1 .
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present study, although the increase of sCr at 24 h from baseline was small, renal function at 1 year after the procedure deteriorated. Even small changes in the deterioration of renal function have been shown to have a significant impact on long-term mortality. 18, 19 Thus, it is advantageous to attend to small changes in renal function in the early phase to predict long-term renal outcome and mortality. Pre-existing renal dysfunction, diabetes, high age, diuretics, hypertension and the amount of contrast medium have been reported as risk factors for CIN. 20 In the present study, these risk factors for CIN did not correlate with the change in eGFR at 1 year after angiography in multivariate analysis. The early decrease in eGFR and increase in oxidative stress could be more useful to predict the renal prognosis after angiography. The use of diuretics correlated with the change in eGFR at 1 year after angiography in the univariate model. Furosemide-induced diuresis might result in hypovolemia, which might increase the risk of renal tubule injury induced by contrast media. 21 Hypertension and diabetes are major risk factors for chronic kidney disease. 22 In the present study, the BP levels and the glycated hemoglobin levels did not change during the study period. It could be excluded that the chronic renal insufficiency was due to the progression of hypertension and diabetes.
Previous experimental studies suggest that administration of contrast medium increases the production of nephrotoxic oxygen free radicals. 23, 24 Oxidative stress is thought to cause renal tubular toxicity and renal medullary ischemia, 25 both of which are considered as main causes of CIN. Antioxidants such as allopurinol and N-acetylcysteine are known to inhibit ischemic cell death in the kidney 26,27 and to prevent CIN. 12,24,28 Furthermore, the adenosine antagonist, theophylline, which also has antioxidant effects, 29 reduced the incidence of CIN. 30, 31 Masuda et al previously reported that hydration with sodium bicarbonate reduces the incidence of renal replacement therapy and death in patients with chronic kidney disease undergoing an emergent coronary procedure. 32 A possible mechanism for the prevention of CIN with sodium bicarbonate is inhibition of oxidant injury through alkalizing renal tubular fluid. In the present study, we directly demonstrated a relationship between contrast-induced oxidative stress and chronic renal insufficiency. It is the limitation that we did not show whether the increase of oxidative stress after angiography was transient or maintained for a long-term period because we collected urine samples only at baseline and 24 h after angiography. If the increase of oxidative stress prolonged, the sCr level should continue to increase. It is likely to be considered that the contrast-induced elevated oxidative stress was transient because a rise in sCr level usually returns to the basal level within 2 weeks. 15 It might also be appropriate to consider that the patients with an increased sCr level after coronary angiography, even within a normal sCr level range, have inapparent renal insufficiency. Administration of a contrast agent might work as a challenge test to become evident in renal insufficiency. A transient increase in sCr and oxidative stress might just reflect the underlying renal insufficiency. In the present study, although we used urinary F2-isoprostane as one of the oxidative stress markers, the kinetics of F2-isoprostane can be an important limitation for the present study. We could not find any relationships between the urinary F2-isoprostane level and eGFR or sCr in the present study (data not shown); however, it is possible that renal function affects the F2-isoprostane excretion.
Conclusion
In this prospective cohort of patients undergoing routine coronary angiography, the chronic renal insufficiency was correlated with the early increase in oxidative stress as well as the decrease in eGFR. Therefore, patients with an increase in oxidative stress and sCr level measured at 24 h after a contrast procedure should undergo more careful long-term follow-up of sCr and appropriate medical intervention.
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